Public Notification: Linsen Double Caulis Plus (靈仙双藤素) Contains Hidden Drug Ingredient

[10-30-2017] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Linsen Double Caulis Plus (靈仙双藤素), a product promoted for joint, gout, and back pain on various websites, including http://www.tranpharma.com, and possibly in some retail stores.Image of Linsen Double Caulis 1 Image of Linsen Double Caulis 2 

FDA laboratory analysis confirmed that Linsen Double Caulis Plus (靈仙双藤素) contains dexamethasone. Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Corticosteroid use can impair a person’s ability to fight infections and can cause high blood sugar levels, muscle injuries and psychiatric problems. When corticosteroids are taken for a prolonged period, or at high doses, they can suppress the adrenal gland.  Abrupt discontinuation can cause withdrawal symptoms.       

Consumers taking Linsen Double Caulis Plus (靈仙双藤素) should immediately consult with their health care provider to safely discontinue use of this product. A health care professional should assess the risks of withdrawal from corticosteroids.. Only licensed health care professionals can evaluate patients for the risk or existence of adrenal suppression. To date, FDA is not aware of any reports of adverse events related to this product.

In addition, the undeclared ingredient in Linsen Double Caulis Plus (靈仙双藤素) may cause serious side effects when combined with other medications.

Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program:
Note: This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories. 
For more information:


Contact FDA

Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information

Division of Drug Information (CDER)

Office of Communications

Feedback Form

10001 New Hampshire Avenue

Hillandale Building, 4th Floor

Silver Spring, MD 20993

Page Last Updated: 02/23/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English